NCT05662319: A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia
- State
- Under way
- Phase
- Phase 3
- People
- 91 taking part
- Started
- 1 Feb 2023
- Primary completion
- 25 Mar 2027
- Arms
- All participants
- Results
- None posted
- 22 Dec 2022: Trial registered
- 1 Feb 2023: Trial started